Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2018

18.11.2017 | Original Article

Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?

verfasst von: M. Falk, R. Huhn, F. Behmenburg, St Ritz-Timme, F. Mayer

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Myocardial infarctions go along with biomechanical stress, i.e. stretching of muscle fibres, and the expression of certain marker molecules. We tested if two of those markers, endothelin-1 (ET-1) and growth differentiation factor 15 (GDF-15), can be used as immunohistochemical markers for myocardial ischaemia/infarctions. The study included experiments with an animal model, the isolated perfused Langendorff heart, as well as the investigation of human tissue samples drawn during autopsies. The overall picture of our results showed that GDF-15 is very sensitive and expressed very fast, not only as a consequence of ischaemia/infarctions, but also under other circumstances. Even an expression only caused by agony had to be discussed. ET-1, on the other hand, was less sensitive but only positive in those human cases with ischaemia/infarction that also showed typical alterations in conventional histology. Therefore, both markers did not proof to be a suitable diagnostic tool for myocardial infarctions. However, positive staining for ET-1 was also seen in rats’ hearts that suffered from arrhythmias after electric shock and in the myocardium of the right ventricle in human control cases in which a right heart failure has to be discussed. Thus, especially ET-1 should be subject of further studies that focus on these pathologies.
Literatur
1.
Zurück zum Zitat Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRefPubMed Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113:215–220CrossRefPubMed
3.
Zurück zum Zitat Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292CrossRefPubMed Cleutjens JP, Kandala JC, Guarda E et al (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292CrossRefPubMed
7.
Zurück zum Zitat Cummings PM, Trelka DP, Springer KM (2011) Atlas of forensic histopathology. Cambridge University Press, Cambridge; New YorkCrossRef Cummings PM, Trelka DP, Springer KM (2011) Atlas of forensic histopathology. Cambridge University Press, Cambridge; New YorkCrossRef
8.
Zurück zum Zitat Thomsen H, Schulz A, Bhakdi S (1990) Immunhistochemische C5b-9-komplement-komplex-darstellung in frühstadien der herzmuskelnekrosen am paraffinschnitt. Int J Legal Med 103:199–206CrossRef Thomsen H, Schulz A, Bhakdi S (1990) Immunhistochemische C5b-9-komplement-komplex-darstellung in frühstadien der herzmuskelnekrosen am paraffinschnitt. Int J Legal Med 103:199–206CrossRef
9.
Zurück zum Zitat Bi H, Yang Y, Huang J et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84CrossRefPubMedPubMedCentral Bi H, Yang Y, Huang J et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bootcov MR, Bauskin AR, Valenzuela SM et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94:11514–11519CrossRefPubMedPubMedCentral Bootcov MR, Bauskin AR, Valenzuela SM et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94:11514–11519CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700CrossRefPubMed Shi Y, Massagué J (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700CrossRefPubMed
14.
Zurück zum Zitat Fairlie WD, Moore AG, Bauskin AR et al (1999) MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65:2–5CrossRefPubMed Fairlie WD, Moore AG, Bauskin AR et al (1999) MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 65:2–5CrossRefPubMed
15.
Zurück zum Zitat Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol Cell Biol 20:3742–3751CrossRefPubMedPubMedCentral Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol Cell Biol 20:3742–3751CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Masaki T, Yanagisawa M, Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391–421CrossRefPubMed Masaki T, Yanagisawa M, Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391–421CrossRefPubMed
21.
Zurück zum Zitat Loennechen JP, Stoylen A, Beisvag V et al (2001) Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Phys 280:H2902–H2910 Loennechen JP, Stoylen A, Beisvag V et al (2001) Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am J Phys 280:H2902–H2910
22.
Zurück zum Zitat Oie E, Vinge LE, Tønnessen T et al (1997) Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Phys 273:H1727–H1736 Oie E, Vinge LE, Tønnessen T et al (1997) Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. Am J Phys 273:H1727–H1736
23.
Zurück zum Zitat Tønnessen T, Lunde PK, Giaid A et al (1998) Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide. Cardiovasc Res 39:633–643CrossRefPubMed Tønnessen T, Lunde PK, Giaid A et al (1998) Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide. Cardiovasc Res 39:633–643CrossRefPubMed
24.
Zurück zum Zitat Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57PubMedPubMedCentral Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57PubMedPubMedCentral
25.
Zurück zum Zitat Ono K, Matsumori A, Shioi T et al (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149–156CrossRefPubMed Ono K, Matsumori A, Shioi T et al (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149–156CrossRefPubMed
26.
Zurück zum Zitat Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 275:H250–H258CrossRef Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol Heart Circ Physiol 275:H250–H258CrossRef
28.
Zurück zum Zitat Sütsch G, Kiowski W, Yan XW et al (1998) Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98:2262–2268CrossRefPubMed Sütsch G, Kiowski W, Yan XW et al (1998) Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98:2262–2268CrossRefPubMed
29.
Zurück zum Zitat Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225–228CrossRefPubMed Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989) Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225–228CrossRefPubMed
30.
Zurück zum Zitat Takuwa N, Takuwa Y, Yanagisawa M et al (1989) A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264:7856–7861PubMed Takuwa N, Takuwa Y, Yanagisawa M et al (1989) A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264:7856–7861PubMed
31.
Zurück zum Zitat Ito H, Hirata Y, Hiroe M et al (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209–215CrossRefPubMed Ito H, Hirata Y, Hiroe M et al (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209–215CrossRefPubMed
32.
Zurück zum Zitat Molenaar P, O’reilly G, Sharkey A et al (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538CrossRefPubMed Molenaar P, O’reilly G, Sharkey A et al (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538CrossRefPubMed
Metadaten
Titel
Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?
verfasst von
M. Falk
R. Huhn
F. Behmenburg
St Ritz-Timme
F. Mayer
Publikationsdatum
18.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2018
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1726-z

Weitere Artikel der Ausgabe 2/2018

International Journal of Legal Medicine 2/2018 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin